论文信息 - Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-controlled study by the ALLG - 字舞流文

Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-controlled study by the ALLG

P. Marlton | A. Roberts | A. Wei | M. Levis | S. Ramanathan | C. Tiley | A. Enjeti | A. Schwarer | T. Rawling | J. Seymour | K. Morris | G. Kennedy | I. Tiong | U. Hahn | J. D’Rozario | A. Bajel | M. Latimer | H. Iland | C. Fong | D. Hiwase | J. Leadbetter | S. Yuen | E. Verner | J. Reynolds | I. Bilmon | G. Cull | Michael Murray | N. Murphy | J. Taper | D. M. Ong | S. Loo | Meaghan Wall | Simon Z. He | Natasha S. Anstee | Leesa Rowley | Stephen B Ting